L-carnitine decreases glycolysis in liquid-stored platelets. 2000

J D Sweeney, and A J Blair, and T A Cheves, and S Dottori, and A Arduini
Herbert C. Lichtmann Blood Bank and Transfusion Medicine Research Unit, The Miriam Hospital, Providence, Rhode Island 01906, USA. jsweeney@lifespan.org

BACKGROUND The platelet storage lesion is characterized metabolically by a pH decrease associated with lactic acid generation; a change in platelet morphology from discoid to spherical; a diminished response to in vitro challenge tests, such as the hypotonic shock response (HSR) and extent of shape change (ESC); increased surface P-selectin expression; and decreased in vivo recovery and survival. Altering storage conditions to improve these measures could allow for extension of the duration of in vitro storage. METHODS ABO-identical paired platelet concentrates were pooled and then equally divided into two plastic bags. Either L-carnitine (LC) or an equal volume of saline (control) was added to one container of each pair. Platelets were stored at 20 to 24 degrees C for 5 to 10 days or at 1 to 6 degrees C for 5 days at various concentrations of LC between 0.1 and 15 mM: At the end of storage, pH, glucose consumption, lactate generation, HSR, ESC, and surface P-selectin expression were measured. In different experiments, paired platelet concentrates were spiked with a Staphylococcus epidermidis suspension in the presence and absence of L-carnitine at a concentration of 5 mM: RESULTS At 20 to 24 degrees C and concentrations of LC between 0.1 and 5 mM:, there was evidence of better pH preservation, less glucose consumption, and less lactate generation. Only with storage beyond 5 days was a difference present in either surface P-selectin expression or HSR. An L-carnitine concentration of 5 mM: appeared optimal. L-carnitine did not enhance the growth of bacteria after 7 to 8 days of storage. CONCLUSIONS LC at 5 mM: may improve the quality of platelet concentrates that are stored beyond 5 days. There was no indication that LC at this concentration would promote bacterial growth. It may be a useful additive to platelet preservation.

UI MeSH Term Description Entries
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D001793 Blood Preservation The process by which blood or its components are kept viable outside of the organism from which they are derived (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism). Blood Preservations,Preservation, Blood,Preservations, Blood
D002331 Carnitine A constituent of STRIATED MUSCLE and LIVER. It is an amino acid derivative and an essential cofactor for fatty acid metabolism. Bicarnesine,L-Carnitine,Levocarnitine,Vitamin BT,L Carnitine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006019 Glycolysis A metabolic process that converts GLUCOSE into two molecules of PYRUVIC ACID through a series of enzymatic reactions. Energy generated by this process is conserved in two molecules of ATP. Glycolysis is the universal catabolic pathway for glucose, free glucose, or glucose derived from complex CARBOHYDRATES, such as GLYCOGEN and STARCH. Embden-Meyerhof Pathway,Embden-Meyerhof-Parnas Pathway,Embden Meyerhof Parnas Pathway,Embden Meyerhof Pathway,Embden-Meyerhof Pathways,Pathway, Embden-Meyerhof,Pathway, Embden-Meyerhof-Parnas,Pathways, Embden-Meyerhof
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015925 Cryopreservation Preservation of cells, tissues, organs, or embryos by freezing. In histological preparations, cryopreservation or cryofixation is used to maintain the existing form, structure, and chemical composition of all the constituent elements of the specimens. Cryofixation,Cryonic Suspension,Cryonic Suspensions,Suspension, Cryonic

Related Publications

J D Sweeney, and A J Blair, and T A Cheves, and S Dottori, and A Arduini
January 2004, Journal of clinical apheresis,
J D Sweeney, and A J Blair, and T A Cheves, and S Dottori, and A Arduini
January 1966, Journal of applied physiology,
J D Sweeney, and A J Blair, and T A Cheves, and S Dottori, and A Arduini
June 1989, Transfusion,
J D Sweeney, and A J Blair, and T A Cheves, and S Dottori, and A Arduini
May 2015, Mutation research,
J D Sweeney, and A J Blair, and T A Cheves, and S Dottori, and A Arduini
June 2020, Transfusion medicine (Oxford, England),
J D Sweeney, and A J Blair, and T A Cheves, and S Dottori, and A Arduini
May 1987, Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression,
J D Sweeney, and A J Blair, and T A Cheves, and S Dottori, and A Arduini
July 1999, Experimental eye research,
J D Sweeney, and A J Blair, and T A Cheves, and S Dottori, and A Arduini
January 1956, British journal of haematology,
J D Sweeney, and A J Blair, and T A Cheves, and S Dottori, and A Arduini
January 2010, Pediatric endocrinology, diabetes, and metabolism,
J D Sweeney, and A J Blair, and T A Cheves, and S Dottori, and A Arduini
December 2017, Turkish journal of haematology : official journal of Turkish Society of Haematology,
Copied contents to your clipboard!